NCT03118999

Plasma Level of Various Omega-3 Lipids

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 24 (actual)
• Sponsor: Société des Produits Nestlé (SPN) · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Accepted

Summary

The primary objective of this study is to evaluate the pharmacokinetic properties of 3 OM3 oils after a single-dose administration in healthy volunteers

Detailed description

This is a single center, open design, randomized, controlled, cross-over trial with 3 test periods and 3 products (one test period per product). The three different test periods will be separated by a washout period of at least 6 days (up to 21 days).

Conditions

• Healthy

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	OM3-FFA	Comparison of the effects of OM3-FFA versus OM3-MAG and OM3-EE in a crossover design
DIETARY_SUPPLEMENT	OM3-MAG	Comparison of the effects of OM3-MAG versus OM3-FFA and OM3-EE in a crossover design
DIETARY_SUPPLEMENT	OM3-EE	Comparison of the effects of OM3-EE versus OM3-FFA and OM3-MAG in a crossover design

Timeline

• Start date: 2017-02-28
• Primary completion: 2017-04-30
• Completion: 2017-08-31
• First posted: 2017-04-18
• Last updated: 2018-09-20

Locations

1 site across 1 country: Switzerland